» Articles » PMID: 17804739

5-Azacytidine Induced Methyltransferase-DNA Adducts Block DNA Replication in Vivo

Overview
Journal Cancer Res
Specialty Oncology
Date 2007 Sep 7
PMID 17804739
Citations 61
Authors
Affiliations
Soon will be listed here.
Abstract

5-Azacytidine (aza-C) and its derivatives are cytidine analogues used for leukemia chemotherapy. The primary effect of aza-C is the prohibition of cytosine methylation, which results in covalent methyltransferase-DNA (MTase-DNA) adducts at cytosine methylation sites. These adducts have been suggested to cause chromosomal rearrangements and contribute to cytotoxicity, but the detailed mechanisms have not been elucidated. We used two-dimensional agarose gel electrophoresis and electron microscopy to analyze plasmid pBR322 replication dynamics in Escherichia coli cells grown in the presence of aza-C. Two-dimensional gel analysis revealed the accumulation of specific bubble and Y molecules, dependent on overproduction of the cytosine MTase EcoRII (M.EcoRII) and treatment with aza-C. Furthermore, a point mutation that eliminates a particular EcoRII methylation site resulted in disappearance of the corresponding bubble and Y molecules. These results imply that aza-C-induced MTase-DNA adducts block DNA replication in vivo. RecA-dependent X structures were also observed after aza-C treatment. These molecules may be generated from blocked forks by recombinational repair and/or replication fork regression. In addition, electron microscopy analysis revealed both bubbles and rolling circles (RC) after aza-C treatment. These results suggest that replication can switch from theta to RC mode after a replication fork is stalled by an MTase-DNA adduct. The simplest model for the conversion of theta to RC mode is that the blocked replication fork is cleaved by a branch-specific endonuclease. Such replication-dependent DNA breaks may represent an important pathway that contributes to genome rearrangement and/or cytotoxicity.

Citing Articles

Aldehyde-induced DNA-protein crosslinks- DNA damage, repair and mutagenesis.

Blouin T, Saini N Front Oncol. 2024; 14:1478373.

PMID: 39328207 PMC: 11424613. DOI: 10.3389/fonc.2024.1478373.


Role of liquid-liquid phase separation in cancer: Mechanisms and therapeutic implications.

Li X, Yu Z Cancer Innov. 2024; 3(5):e144.

PMID: 39290787 PMC: 11407098. DOI: 10.1002/cai2.144.


Mechanisms controlling replication fork stalling and collapse at topoisomerase 1 cleavage complexes.

Westhorpe R, Roske J, Yeeles J Mol Cell. 2024; 84(18):3469-3481.e7.

PMID: 39236719 PMC: 7617106. DOI: 10.1016/j.molcel.2024.08.004.


Transcription-coupled repair of DNA-protein cross-links depends on CSA and CSB.

Carnie C, Acampora A, Bader A, Erdenebat C, Zhao S, Bitensky E Nat Cell Biol. 2024; 26(5):797-810.

PMID: 38600235 PMC: 11098753. DOI: 10.1038/s41556-024-01391-1.


The viral etiology of EBV-associated gastric cancers contributes to their unique pathology, clinical outcomes, treatment responses and immune landscape.

Salnikov M, MacNeil K, Mymryk J Front Immunol. 2024; 15:1358511.

PMID: 38596668 PMC: 11002251. DOI: 10.3389/fimmu.2024.1358511.